These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16108100)

  • 1. A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain.
    Curtis MA; Waldvogel HJ; Synek B; Faull RL
    J Chem Neuroanat; 2005 Jul; 30(1):55-66. PubMed ID: 16108100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain.
    Curtis MA; Penney EB; Pearson J; Dragunow M; Connor B; Faull RL
    Neuroscience; 2005; 132(3):777-88. PubMed ID: 15837138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.
    Curtis MA; Faull RL; Glass M
    J Chem Neuroanat; 2006 Apr; 31(3):210-5. PubMed ID: 16533591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.
    Norris PJ; Waldvogel HJ; Faull RL; Love DR; Emson PC
    Neuroscience; 1996 Jun; 72(4):1037-47. PubMed ID: 8735228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
    Ma L; Nicholson LF
    Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective sparing of a class of striatal neurons in Huntington's disease.
    Ferrante RJ; Kowall NW; Beal MF; Richardson EP; Bird ED; Martin JB
    Science; 1985 Nov; 230(4725):561-3. PubMed ID: 2931802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degeneration of pyramidal projection neurons in Huntington's disease cortex.
    Cudkowicz M; Kowall NW
    Ann Neurol; 1990 Feb; 27(2):200-4. PubMed ID: 2138444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.
    Kim J; Waldvogel HJ; Faull RL; Curtis MA; Nicholson LF
    J Neurochem; 2015 Sep; 134(5):927-42. PubMed ID: 26011179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin expression in Huntington's diseased human brain.
    Vis JC; Nicholson LF; Faull RL; Evans WH; Severs NJ; Green CR
    Cell Biol Int; 1998 Nov; 22(11-12):837-47. PubMed ID: 10873295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.
    Myers RH; Vonsattel JP; Paskevich PA; Kiely DK; Stevens TJ; Cupples LA; Richardson EP; Bird ED
    J Neuropathol Exp Neurol; 1991 Nov; 50(6):729-42. PubMed ID: 1836225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia.
    Curtis MA; Eriksson PS; Faull RL
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):528-32. PubMed ID: 17439428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus.
    Butterworth J
    J Neurochem; 1986 Aug; 47(2):583-7. PubMed ID: 2874190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D; De Quidt ME; Emson PC
    Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.
    Morton AJ; Nicholson LF; Faull RL
    Neuroscience; 1993 Mar; 53(1):159-68. PubMed ID: 7682296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain.
    Curtis MA; Penney EB; Pearson AG; van Roon-Mom WM; Butterworth NJ; Dragunow M; Connor B; Faull RL
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):9023-7. PubMed ID: 12853570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis.
    Pearson AG; Curtis MA; Waldvogel HJ; Faull RL; Dragunow M
    Neuroscience; 2005; 133(2):437-51. PubMed ID: 15878807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.
    Mazurová Y; Gunčová I; Látr I; Rudolf E
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):486-99. PubMed ID: 21495959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.